5.21
Portale Hypertension
Die portale Hypertonie ist ein Anstieg des Blutdrucks im Pfortadersystem. Normalerweise liegt dieser Druck unter 5 mmHg. Sie gilt als klinisch signifi…
Portalhypertonie ist definiert als ein Anstieg des portalvenösen Drucks über 5 Millimeter Quecksilber.
Wenn sie 10 bis 12 mmHg überschreitet, wird die Erkrankung klinisch bedeutsam und beginnt, die normale Durchblutung zu stören.
Die häufigste Ursache ist Leberzirrhose, bei der fibrotische Narben in der Leber den Blutfluss blockieren.
Andere Ursachen können als prähepatisch klassifiziert werden, wie zum Beispiel Torvenenthrombose, intrahepatisch, wie schistosomiasis, und posthepatisch, wie rechte Herzinsuffizienz.
Mit zunehmender Leberresistenz wird das Blut aus dem Magen-Darm-Trakt durch Kollateralgefäße geleitet, die die Leber umgehen. Diese Kollateralbahnen – wie die in der Speiseröhre – helfen, den Portaldruck zu senken, ermöglichen es aber auch dem Blut, den Leberstoffwechsel zu umgehen.
Diese verminderte Verarbeitung führt dazu, dass sich Toxine wie Ammoniak im Blut ansammeln und das Gehirn erreichen, was zur leberartigen Enzephalopathie führt.
Gleichzeitig verursacht der steigende Druck eine venöse Verstopfung der nahegelegenen Organe. Varizen können sich in gefährdeten Bereichen wie Speiseröhre und Magen bilden. Diese Varizen können platzen, was zu starken Blutungen führt.
View the full transcript and gain access to JoVE Core videos
Q1: What pressure level defines clinically significant portal hypertension?
Portal hypertension becomes clinically significant when portal venous pressure exceeds 10 to 12 millimeters of mercury, compared to the normal level below 5 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge, disrupting normal circulation and triggering pathophysiological changes throughout the body.
Q2: Why does cirrhosis cause portal hypertension?
Cirrhosis causes portal hypertension through fibrotic scarring within the liver that obstructs blood flow. This fibrosis narrows or obstructs the intrahepatic vasculature, increasing resistance to portal blood flow. As resistance rises, blood from the gastrointestinal tract cannot pass through the portal system efficiently, leading to increased pressure.
Q3: What are prehepatic and posthepatic causes of portal hypertension?
Prehepatic causes, such as portal vein thrombosis, obstruct blood flow before it reaches the liver. Posthepatic causes, like right-sided heart failure, impede blood outflow from the liver by elevating central venous pressure, which is transmitted backward into the hepatic circulation, increasing upstream pressure.
Q4: How do portosystemic collaterals develop and what are their consequences?
When liver resistance increases, blood is rerouted through portosystemic collaterals—alternative vessels that bypass the liver. While these collaterals relieve pressure, they allow blood to bypass hepatic metabolism, causing toxins like ammonia to accumulate in systemic circulation and reach the brain, potentially leading to hepatic encephalopathy.
Q5: Where do esophageal varices form and why are they dangerous?
Esophageal varices are dilated veins that form in the esophagus and stomach due to rising portal pressure causing venous congestion in nearby organs. These fragile varices are prone to rupture, posing a significant risk of life-threatening gastrointestinal bleeding when damaged or stressed.
Q6: What pulmonary complications can result from portal hypertension?
Portal hypertension can cause hepatopulmonary syndrome, characterized by intrapulmonary vascular dilation and impaired oxygenation, and portopulmonary hypertension, marked by elevated pulmonary arterial pressure from altered vascular tone. These complications demonstrate how portal hypertension extends beyond the liver, affecting multiple organ systems.
Q7: How does schistosomiasis contribute to portal hypertension?
Schistosomiasis is a parasitic infection that affects the hepatic portal system and often leads to periportal fibrosis. This fibrotic scarring impedes blood flow through the liver, increasing resistance and elevating portal venous pressure, similar to the mechanisms seen in cirrhosis-related disease.